This document provides information about the medication metoprolol (Lopressor) including its classification, dose, route of administration, time/frequency, peak onset and duration. It describes the patient's indication for receiving this medication as hypertension and decreased blood pressure and heart rate for prevention of MI and decreased mortality in recent MI patients. The key nursing implications are monitoring for bradycardia and hypotension, educating the patient about safe administration and reporting side effects, and evaluating treatment response through decreased blood pressure, reduced angina attacks, and increased activity tolerance.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
This document provides information about the medication metoprolol (Lopressor) including its classification, dose, route of administration, time/frequency, peak onset and duration. It describes the patient's indication for receiving this medication as hypertension and decreased blood pressure and heart rate for prevention of MI and decreased mortality in recent MI patients. The key nursing implications are monitoring for bradycardia and hypotension, educating the patient about safe administration and reporting side effects, and evaluating treatment response through decreased blood pressure, reduced angina attacks, and increased activity tolerance.
This document provides information about the medication metoprolol (Lopressor) including its classification, dose, route of administration, time/frequency, peak onset and duration. It describes the patient's indication for receiving this medication as hypertension and decreased blood pressure and heart rate for prevention of MI and decreased mortality in recent MI patients. The key nursing implications are monitoring for bradycardia and hypotension, educating the patient about safe administration and reporting side effects, and evaluating treatment response through decreased blood pressure, reduced angina attacks, and increased activity tolerance.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
This document provides information about the medication metoprolol (Lopressor) including its classification, dose, route of administration, time/frequency, peak onset and duration. It describes the patient's indication for receiving this medication as hypertension and decreased blood pressure and heart rate for prevention of MI and decreased mortality in recent MI patients. The key nursing implications are monitoring for bradycardia and hypotension, educating the patient about safe administration and reporting side effects, and evaluating treatment response through decreased blood pressure, reduced angina attacks, and increased activity tolerance.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
Download as doc, pdf, or txt
You are on page 1of 2
NURS 1566 Clinical Form 3: Clinical Medications Worksheets
(You will need to make additional copies of these forms)
Generic Name Trade Name Classification Dose Route Time/frequency
metoprolol Lopressor antianginals, 100 mg po BID antihypertensives Peak Onset Duration Normal dosage range unknown 15 min 6-12 hr 25-100mg/day as a single dose initially or 2 divided doses; may be increased q 7 days as needed up to 450mg/day (for angina give in divided doses). Why is your patient getting this medication For IV meds, compatibility with IV drips and/or Hypertension. Decreased blood pressure and heart solutions rate. Prevention of MI and decreased mortality in patients N/A with recent MI Mechanism of action and indications Nursing Implications (what to focus on) (Why med ordered) Contraindications/warnings/interactions Blocks stimulation of beta1(myocardial)-adrenergic Geriatric patients (increased sensitivity to beta blockers; receptors. Does not usually affect beta2(pulmonary, initial dosage reduction recommended) vascular, uterine)-adrenergic receptor sites. Thyrotoxicosis (may mask symptoms) Common side effects fatigue, weakness, impotence, anxiety, depression, dizziness, drowsiness, insomnia, memory loss, mental status changes, nervousness, nightmares, hypotension, peripheral vasoconstriction, BRADYCARDIA, CHF, PULMONARY EDEMA Interactions with other patient drugs, OTC or Lab value alterations caused by medicine herbal medicines (ask patient specifically) May cause ↑ BUN, serum lipoprotein, potassium, triglyceride, and uric None for this patient acid levels May cause ↑ ANA titers, May cause ↑ in blood glucose levels, May cause ↑ serum alkaline phosphatase, LDH, AST, and ALT levels Be sure to teach the patient the following about this medication Instruct patient to take medication as directed, at the same time each day, even if feeling well; do not skip or double up on missed doses. Take missed doses as soon as possible up to 8 hr before next dose. Abrupt withdrawal may precipitate life-threatening arrhythmias, hypertension, or myocardial ischemia Advise patient to change positions slowly to minimize orthostatic hypotension. Teach patient and family how to check pulse daily and blood pressure biweekly and to report significant changes to health care professional. Caution patient that this medication may increase sensitivity to cold. Instruct patient to consult health care professional before taking any OTC medications or herbal products, especially cold preparations, concurrently with this medication. Patients on antihypertensive therapy should also avoid excessive amounts of caffeinated coffee, tea, and cola. Advise patient to notify health care professional if slow pulse, difficulty breathing, wheezing, cold hands and feet, dizziness, light- headedness, confusion, depression, rash, fever, sore throat, unusual bleeding, or bruising occurs. Reinforce the need to continue additional therapies for hypertension (weight loss, sodium restriction, stress reduction, regular exercise, moderation of alcohol consumption, and smoking cessation). Medication controls but does not cure hypertension Medication does not block sweating as a sign of hypoglycemia Nursing Process- Assessment Assessment Evaluation (Pre-administration assessment) Why would you hold or not give this Check after giving med? Decrease in blood pressure Take apical pulse before Monitor intake and output ratios and daily Reduction in frequency of administering. If <50 bpm or if weights. Assess routinely for signs and anginal attacks arrhythmia occurs, withhold medication and notify physician or symptoms of CHF (dyspnea, Increase in activity tolerance other health care professional rales/crackles, weight gain, peripheral Prevention of MI Monitor blood pressure, ECG, edema, jugular venous distention), and pulse frequently during dose notify health care professional if slow adjustment and periodically pulse, difficulty breathing, wheezing, cold during therapy. Monitor frequency hands and feet, dizziness, light- of prescription refills to determine headedness, confusion, depression, rash, compliance fever, sore throat, unusual bleeding, or bruising occurs, If <50 bpm or if arrhythmia occurs, withhold medication and notify physician or other health care professional